December 12, 2019

October 21, 2015

Please reload

Recent Posts

POEM Update

December 12, 2019

Please reload

Featured Posts

Efficacy of probiotic treatment with Bifidobacterium longum 536 for induction of remission in active ulcerative colitis: A randomized, double-blinded, placebo-controlled multicenter trial

October 9, 2015

More on the benefits of probiotics. Read here.


  • In total, 63% of patients receiving BB536 showed clinical remission (UC disease activity index [UCDAI] ≤ 2) at week 8 compared to 52% of those receiving placebo (P=0.395).

  • The authors observed a significant decrease of UCDAI scores (3.5±1.9 at baseline to 2.5±1.7 at week 8) in the BB536 group (P<0.01), while there was no significant decrease in the placebo group (P=0.88).

  • There was also a significant decrease in the Rachmilewitz endoscopic index (EI) and the Mayo sub-score at week 8 in the BB536 group, while there was no significant decrease in the placebo group.

  • Besides the single patient in the BB536 group who complained of a mild side effect, no other adverse effects were observed.










Please reload

Follow Us
Search By Tags